• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Histopathological study and management of benign breast disease at a tertiary care hospital

    Dr. Avinash Chandra S

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 277-283

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Benign breast disease is primarily a phenomenon seen in reproductive age group. They are
thought to be largely hormone induced. Benign breast disease is 4-5 times more common then
breast cancer. The study includes patient attending surgical outpatient department and
admitted to surgical wards with breast lump during the study period. Most of the patients
underwent excision-85 patient (77.27%) followed by microdochotomy-4 (3.63%)and I & D-4
(3.63%).Simple mastectomy also done in 4 (3.63%) patients. Wide excision biopsy was done
in 3 (2.72%) patient. Majority of the patients 90 patients (81.81%) did not have any postoperative
complications, whereas 12 patients (10.90%) had discharge from wound and 5
patients (4.54%) had wound gape due to infection.
Keywords:
    benign breast disease wide excision biopsy microdiscectomy
  • PDF (229 K)
  • XML
(2022). Histopathological study and management of benign breast disease at a tertiary care hospital. European Journal of Molecular & Clinical Medicine, 9(1), 277-283.
Dr. Avinash Chandra S. "Histopathological study and management of benign breast disease at a tertiary care hospital". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 277-283.
(2022). 'Histopathological study and management of benign breast disease at a tertiary care hospital', European Journal of Molecular & Clinical Medicine, 9(1), pp. 277-283.
Histopathological study and management of benign breast disease at a tertiary care hospital. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 277-283.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 127
  • PDF Download: 141
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus